Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · Real-Time Price · USD
23.31
+0.12 (0.52%)
At close: Mar 16, 2026, 4:00 PM EDT
23.27
-0.04 (-0.17%)
After-hours: Mar 16, 2026, 7:34 PM EDT
Kodiak Sciences Market Cap
Kodiak Sciences has a market cap or net worth of $1.24 billion as of March 16, 2026. Its market cap has increased by 473.06% in one year.
Market Cap
1.24B
Enterprise Value
1.23B
1-Year Change
473.06%
Ranking
Category
Stock Price
$23.31
Market Cap Chart
Since October 4, 2018, Kodiak Sciences's market cap has increased from $357.63M to $1.24B, an increase of 245.76%. That is a compound annual growth rate of 18.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 1.44B | -16.63% |
| Dec 31, 2025 | 1.73B | 231.69% |
| Dec 31, 2024 | 522.39M | 228.65% |
| Dec 29, 2023 | 158.95M | -57.33% |
| Dec 30, 2022 | 372.50M | -91.44% |
| Dec 31, 2021 | 4.35B | -41.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AtaiBeckley | 1.34B |
| Rapport Therapeutics | 1.33B |
| MBX Biosciences | 1.33B |
| Vir Biotechnology | 1.29B |
| Zenas BioPharma | 1.29B |
| Corvus Pharmaceuticals | 1.29B |
| Precigen | 1.24B |
| Immatics | 1.24B |